Format

Send to

Choose Destination
See comment in PubMed Commons below
J Neuroimmunol. 2008 Aug 30;200(1-2):1-10. doi: 10.1016/j.jneuroim.2008.05.017. Epub 2008 Jul 22.

Mutant amyloid-beta-sensitized dendritic cells as Alzheimer's disease vaccine.

Author information

1
Johnnie B. Byrd, Sr., Alzheimer's Center and Research Institute, 4001 East Fletcher Avenue, Tampa, FL 33613, United States. ccao@byrdinstitute.org

Abstract

Vaccines using bone marrow-derived dendritic cells (DCs) sensitized to Abeta 1-42 peptide and other mutant peptides were tested on BALB/c and APP(SW) transgenic mice. Wild type Abeta 1-42-sensitized DC vaccine (DCSV) produced no response, but all peptides with a T-cell epitope mutation induced antibody responses without inflammation. DCSV with Abeta 1-25 peptide with mutated T-cell epitope failed to induce antibody response, while DCSV with Abeta 1-35 with mutated T-cell epitope produced a strong antibody response. The entire T-cell epitope is required in a DC vaccine to induce antibody response. DCSV with Abeta peptide carrying the entire mutant T-cell epitope may be an appropriate vaccine against AD.

PMID:
18649951
DOI:
10.1016/j.jneuroim.2008.05.017
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center